FI970715A - Menetelmä luun parantamiseksi ja murtuman korjaamiseksi - Google Patents

Menetelmä luun parantamiseksi ja murtuman korjaamiseksi Download PDF

Info

Publication number
FI970715A
FI970715A FI970715A FI970715A FI970715A FI 970715 A FI970715 A FI 970715A FI 970715 A FI970715 A FI 970715A FI 970715 A FI970715 A FI 970715A FI 970715 A FI970715 A FI 970715A
Authority
FI
Finland
Prior art keywords
fractures
correcting
procedures
image
healing bones
Prior art date
Application number
FI970715A
Other languages
English (en)
Swedish (sv)
Other versions
FI970715A0 (fi
Inventor
George Joseph Cullinan
Masahiko Sato
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI970715A publication Critical patent/FI970715A/fi
Publication of FI970715A0 publication Critical patent/FI970715A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI970715A 1994-08-22 1997-02-20 Menetelmä luun parantamiseksi ja murtuman korjaamiseksi FI970715A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/294,130 US5502074A (en) 1994-08-22 1994-08-22 Benzothiophenes for bone healing and fracture repair
PCT/US1995/010618 WO1996005825A1 (en) 1994-08-22 1995-08-21 Methods for bone healing and fracture repair

Publications (2)

Publication Number Publication Date
FI970715A true FI970715A (fi) 1997-02-20
FI970715A0 FI970715A0 (fi) 1997-02-20

Family

ID=23132010

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970715A FI970715A0 (fi) 1994-08-22 1997-02-20 Menetelmä luun parantamiseksi ja murtuman korjaamiseksi

Country Status (20)

Country Link
US (1) US5502074A (fi)
EP (1) EP0769945B1 (fi)
JP (1) JPH10504578A (fi)
KR (1) KR970705385A (fi)
AT (1) ATE240101T1 (fi)
AU (1) AU701946B2 (fi)
CA (1) CA2198012A1 (fi)
CZ (1) CZ51997A3 (fi)
DE (1) DE69530771T2 (fi)
DK (1) DK0769945T3 (fi)
ES (1) ES2197207T3 (fi)
FI (1) FI970715A0 (fi)
HU (1) HUT76855A (fi)
IL (1) IL115016A (fi)
MX (1) MX9701332A (fi)
NO (1) NO970785L (fi)
PH (1) PH31620A (fi)
PT (1) PT769945E (fi)
WO (1) WO1996005825A1 (fi)
ZA (1) ZA956989B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
ES2187195T3 (es) 1998-09-11 2003-05-16 Gerhard Dr Schmidmaier Implantes biologicamente activos.
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
DE4122484A1 (de) * 1991-07-06 1993-01-07 Teves Gmbh Alfred Schaltungsanordnung zur erkennung von radsensordefekten
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW303299B (fi) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
DE69530771T2 (de) 2004-03-11
ZA956989B (en) 1997-02-21
NO970785D0 (no) 1997-02-20
IL115016A (en) 1999-09-22
ES2197207T3 (es) 2004-01-01
WO1996005825A1 (en) 1996-02-29
PT769945E (pt) 2003-09-30
EP0769945B1 (en) 2003-05-14
FI970715A0 (fi) 1997-02-20
AU3409795A (en) 1996-03-14
CA2198012A1 (en) 1996-02-29
AU701946B2 (en) 1999-02-11
DE69530771D1 (de) 2003-06-18
ATE240101T1 (de) 2003-05-15
HUT76855A (en) 1997-12-29
EP0769945A1 (en) 1997-05-02
JPH10504578A (ja) 1998-05-06
IL115016A0 (en) 1995-12-08
US5502074A (en) 1996-03-26
NO970785L (no) 1997-02-20
CZ51997A3 (en) 1997-08-13
KR970705385A (ko) 1997-10-09
DK0769945T3 (da) 2003-06-10
PH31620A (en) 1999-01-12
MX9701332A (es) 1997-05-31
EP0769945A4 (en) 1997-09-03

Similar Documents

Publication Publication Date Title
MY130157A (en) Method of use for inhibiting bone loss and lowering serum cholesterol
AU2267395A (en) Benzofuran derivatives useful as inhibitors of bone resorption
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
FI970715A (fi) Menetelmä luun parantamiseksi ja murtuman korjaamiseksi
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
NO971794L (no) Fremgangsmåte for hemming av tilstander forbundet med bradykinin
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
DE69509657D1 (de) Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung
DE69520741D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der primären endometriumhyperplasie